Aptevo Therapeutics Inc. | Key People and Executives
Marvin L. White
President, Chief Executive Officer & Director
Daniel J. Abdun-Nabi
Director
John E. Niederhuber
Lead Independent Director
Zsolt Pál Harsányi
Independent Director
Grady Grant
Independent Director
Barbara Lopez Kunz
Independent Director
Marvin L. White
President, Chief Executive Officer & Director
Jeffrey G. Lamothe
CFO, Principal Accounting Officer & Senior VP
Jane Gross
Chief Scientific Officer & Senior Vice President
Scott C. Stromatt
Chief Medical Officer & SVP-Clinical Development
Randy J. Maddux
Chief Manufacturing Officer & Senior VP
Daniel J. Abdun-Nabi
Director
Stacey L. Jurchison
Senior Director-Investor Relations
Shawnte Mitchell
Senior Vice President & General Counsel
John E. Niederhuber
Lead Independent Director
Zsolt Pál Harsányi
Independent Director
Grady Grant
Independent Director
Barbara Lopez Kunz
Independent Director
| Address |
2401 4th Avenue
Seattle Washington 98121
United States
|
|
Employees
|
- |
| Website |
http://aptevotherapeutics.com |
| Updated |
07/08/2019 |
| Aptevo Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, commercialization and sale of novel oncology and hematology therapeutics. Its pipeline includes Otlertuzumab, APVO414, APVO436, ROR1 Candidate, and ALG. APV-527. |
